Correlation Between Duopharma Biotech and SSF Home

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and SSF Home at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and SSF Home into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and SSF Home Group, you can compare the effects of market volatilities on Duopharma Biotech and SSF Home and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of SSF Home. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and SSF Home.

Diversification Opportunities for Duopharma Biotech and SSF Home

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Duopharma and SSF is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and SSF Home Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SSF Home Group and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with SSF Home. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SSF Home Group has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and SSF Home go up and down completely randomly.

Pair Corralation between Duopharma Biotech and SSF Home

Assuming the 90 days trading horizon Duopharma Biotech is expected to generate 2.18 times less return on investment than SSF Home. But when comparing it to its historical volatility, Duopharma Biotech Bhd is 1.41 times less risky than SSF Home. It trades about 0.03 of its potential returns per unit of risk. SSF Home Group is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  32.00  in SSF Home Group on September 12, 2024 and sell it today you would earn a total of  3.00  from holding SSF Home Group or generate 9.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  SSF Home Group

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Duopharma Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.
SSF Home Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SSF Home Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, SSF Home is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Duopharma Biotech and SSF Home Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and SSF Home

The main advantage of trading using opposite Duopharma Biotech and SSF Home positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, SSF Home can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SSF Home will offset losses from the drop in SSF Home's long position.
The idea behind Duopharma Biotech Bhd and SSF Home Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes